The molecular chaperone TRAP1 in cancer: From the basics of biology to pharmacological targeting

被引:23
作者
Masgras, Ionica [1 ,2 ]
Laquatra, Claudio [1 ]
Cannino, Giuseppe [1 ]
Serapian, Stefano A. [3 ]
Colombo, Giorgio [3 ]
Rasola, Andrea [1 ]
机构
[1] Univ Padua, Dipartimento Sci Biomed, Viale G Colombo 3, I-35131 Padua, Italy
[2] CNR, Ist Neurosci, Padua, Italy
[3] Univ Pavia, Dipartimento Chim, Via Taramelli 12, I-27100 Pavia, Italy
关键词
TRAP1; Molecular chaperone; Tumor metabolism; Mitochondria; Anti-tumor compounds; MITOCHONDRIAL PERMEABILITY TRANSITION; RECEPTOR-ASSOCIATED PROTEIN-1; HEPATOCELLULAR-CARCINOMA; CLINICAL-SIGNIFICANCE; STRUCTURAL ASYMMETRY; METABOLIC SWITCH; OXIDATIVE STRESS; HSP75; PROTECTS; HSP90; EXPRESSION;
D O I
10.1016/j.semcancer.2021.07.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TRAP1, the mitochondrial component of the Hsp90 family of molecular chaperones, displays important bioenergetic and proteostatic functions. In tumor cells, TRAP1 contributes to shape metabolism, dynamically tuning it with the changing environmental conditions, and to shield from noxious insults. Hence, TRAP1 activity has profound effects on the capability of neoplastic cells to evolve towards more malignant phenotypes. Here, we discuss our knowledge on the biochemical functions of TRAP1 in the context of a growing tumor mass, and we analyze the possibility of targeting its chaperone functions for developing novel anti-neoplastic approaches.
引用
收藏
页码:45 / 53
页数:9
相关论文
共 110 条
  • [1] Rare insights into cancer biology
    Adam, J.
    Yang, M.
    Soga, T.
    Pollard, P. J.
    [J]. ONCOGENE, 2014, 33 (20) : 2547 - 2556
  • [2] TRAP1 Regulates Proliferation, Mitochondrial Function, and Has Prognostic Significance in NSCLC
    Agorreta, Jackeline
    Hu, Jianting
    Liu, Dongxia
    Delia, Domenico
    Turley, Helen
    Ferguson, David J. P.
    Iborra, Francisco
    Pajares, Maria J.
    Larrayoz, Marta
    Zudaire, Isabel
    Pio, Ruben
    Montuenga, Luis M.
    Harris, Adrian L.
    Gatter, Kevin
    Pezzella, Francesco
    [J]. MOLECULAR CANCER RESEARCH, 2014, 12 (05) : 660 - 669
  • [3] PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia
    Aries, Ingrid M.
    Bodaar, Kimberly
    Karim, Salmaan A.
    Chonghaile, Triona Ni
    Hinze, Laura
    Burns, Melissa A.
    Pfirrmann, Maren
    Degar, James
    Landrigan, Jack T.
    Balbach, Sebastian
    Peirs, Sofie
    Menten, Bjorn
    Isenhart, Randi
    Stevenson, Kristen E.
    Neuberg, Donna S.
    Devidas, Meenakshi
    Loh, Mignon L.
    Hunger, Stephen P.
    Teachey, David T.
    Rabin, Karen R.
    Winter, Stuart S.
    Dunsmore, Kimberly P.
    Wood, Brent L.
    Silverman, Lewis B.
    Sallan, Stephen E.
    Van Vlierberghe, Pieter
    Orkin, Stuart H.
    Knoechel, Birgit
    Letai, Anthony G.
    Gutierrez, Alejandro
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2018, 215 (12) : 3094 - 3114
  • [4] Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells
    Basit, Farhan
    van Oppen, Lisanne M. P. E.
    Schoeckel, Laura
    Bossenbroek, Hasse M.
    van Emst-de Vries, Sjenet E.
    Hermeling, Johannes C. W.
    Grefte, Sander
    Kopitz, Charlotte
    Heroult, Melanie
    Willems, Peter H. G. M.
    Koopman, Werner J. H.
    [J]. CELL DEATH & DISEASE, 2017, 8 : e2716 - e2716
  • [5] PRC2 loss amplifies Ras signaling in cancer
    Baude, Annika
    Lindroth, Anders M.
    Plass, Christoph
    [J]. NATURE GENETICS, 2014, 46 (11) : 1154 - 1155
  • [6] THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE: CHANNEL FORMATION BY F-ATP SYNTHASE, INTEGRATION IN SIGNAL TRANSDUCTION, AND ROLE IN PATHOPHYSIOLOGY
    Bernardi, Paolo
    Rasola, Andrea
    Forte, Michael
    Lippe, Giovanna
    [J]. PHYSIOLOGICAL REVIEWS, 2015, 95 (04) : 1111 - 1155
  • [7] Profibrotic IHG-1 complexes with renal disease associated HSPA5 and TRAP1 in mitochondria
    Bhreathnach, Una
    Griffin, Brenda
    Brennan, Eoin
    Ewart, Leah
    Higgins, Debra
    Murphy, Madeline
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2017, 1863 (04): : 896 - 906
  • [8] Hurt, tired and queasy: Specific variants in the ATPase domain of the TRAP1 mitochondrial chaperone are associated with common, chronic "functional" symptomatology including pain, fatigue and gastrointestinal dysmotility
    Boles, Richard G.
    Hornung, Holly A.
    Moody, Alastair E.
    Ortiz, Thomas B.
    Wong, Stacey A.
    Eggington, Julie M.
    Stanley, Christine M.
    Gao, Mu
    Zhou, Hongyi
    McLaughlin, Stephen
    Zare, Amir S.
    Sheldon, Katherine M.
    Skolnick, Jeffrey
    McKernan, Kevin J.
    [J]. MITOCHONDRION, 2015, 23 : 64 - 70
  • [9] A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy
    Bryant, Kelly G.
    Chae, Young Chan
    Martinez, Rogelio L.
    Gordon, John C.
    Elokely, Khaled M.
    Kossenkov, Andrew V.
    Grant, Steven
    Childers, Wayne E.
    Abou-Gharbia, Magid
    Altieri, Dario C.
    [J]. ONCOTARGET, 2017, 8 (68) : 112184 - 112198
  • [10] The Mitochondrial Chaperone Protein TRAP1 Mitigates α-Synuclein Toxicity
    Butler, Erin K.
    Voigt, Aaron
    Lutz, A. Kathrin
    Toegel, Jane P.
    Gerhardt, Ellen
    Karsten, Peter
    Falkenburger, Bjoern
    Reinartz, Andrea
    Winklhofer, Konstanze F.
    Schulz, Joerg B.
    [J]. PLOS GENETICS, 2012, 8 (02):